Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Not Yet Recruiting

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

NCT07034755

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Blood Protein Disorders, Cardiovascular Diseases, +15 more
Locations: The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

NCT06720207

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders

NCT07040189

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +24 more
Locations: LMU Klinikum Munich, Bavaria, Germany

Universitätsklinikum Regensburg Regensburg, Bavaria, Germany

Universitätsklinikum Würzburg Würzburg, Bavaria, Germany

View Trial Details

Not Yet Recruiting

Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study

NCT07026604

Conditions: Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +20 more
Locations: Beijing Tiantan Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

NCT07018271

Conditions: Agranulocytosis, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Efficacy and Safety of the Combination Therapy of Daratumumab, Cabozantinib, Pomalidomide, and Dexamethasone (D-KPd) in the Treatment of High-risk First-time Relapsed or Primary Refractory MM Patients

NCT07015021

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Carfilzomib, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT

NCT06963866

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The Affiliated Hospital oh Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia

NCT06942507

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Not Yet Recruiting

Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)

NCT06931704

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CHU Angers Angers, France

CH Côte Basque Bayonne, France

CHU Besançon Besançon, France

CHU Caen Caen, France

View all 36 locations

View Trial Details

Not Yet Recruiting

A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma

NCT06925958

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions